N
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Price:
34.68
USD
4.46%
Market Closed
Market Cap:
$4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
NL |
Balance Sheet
Balance Sheet Decomposition
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Balance Sheet Decomposition is not available for
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Balance Sheet
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Currency: EUR
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
1
|
1
|
439
|
|
| Cash |
1
|
1
|
0
|
|
| Cash Equivalents |
0
|
0
|
439
|
|
| Total Receivables |
0
|
0
|
2
|
|
| Other Current Assets |
1
|
0
|
8
|
|
| Total Current Assets |
2
|
1
|
448
|
|
| PP&E Net |
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
83
|
|
| Note Receivable |
0
|
0
|
0
|
|
| Long-Term Investments |
138
|
138
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
|
| Total Assets |
140
N/A
|
140
0%
|
532
+281%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
0
|
11
|
|
| Accrued Liabilities |
0
|
0
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
19
|
|
| Total Current Liabilities |
0
|
0
|
35
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Other Liabilities |
12
|
8
|
12
|
|
| Total Liabilities |
12
N/A
|
8
-37%
|
47
+498%
|
|
| Equity | ||||
| Common Stock |
138
|
138
|
599
|
|
| Retained Earnings |
11
|
6
|
115
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
|
| Total Equity |
127
N/A
|
132
+3%
|
485
+268%
|
|
| Total Liabilities & Equity |
140
N/A
|
140
0%
|
532
+281%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
18
|
18
|
82
|
|
Switch to:
Switch to:
See Also
Discover More
